AZD8055 / AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD8055 / AstraZeneca
NCT00973076: Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Checkmark P1 data
Aug 2012 - Aug 2012: P1 data
Completed
1
19
Japan
AZD8055
AstraZeneca
Cancer, Solid Tumors, Advanced Solid Malignancies
12/10
12/10
NCT01194193: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

Withdrawn
1
63
US, Europe
AZD8055
AstraZeneca
Cancer, Advanced Solid Tumours, Lymphomas
 
 
NCT01316809: AZD8055 for Adults With Recurrent Gliomas

Completed
1
22
US
AZD8055
National Cancer Institute (NCI)
Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Malignant Glioma, Brainstem Glioma
04/14
04/16

Download Options